All Journals > Clinical Infectious Diseases > 15 February 2007 > CA‐MRSA and CA‐MSSA Infection Outcomes

Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

CID LISTED AMONG
“MOST INFLUENTIAL”

Clinical Infectious Diseases has been named as one of the "100 Most Influential Journals in Biology and Medicine" of the past 100 years by the Special Libraries Association. The list was compiled by the 680-plus members of SLA’s Biomedical and Life Sciences Division.

See the full list here.

Source: The DBIO 100, the 100 Most Influential Journals in Biology & Medicine over the last 100 Years

In the News

Featured in MSNBC
"Germs and flu are up; infection control is down" June 9, 2009
Trends in the Incidence of Methicillin‐Resistant Staphylococcus aureus Infection in Children’s Hospitals in the United States
Jeffrey S. Gerber, Susan E. Coffin, Sarah A. Smathers, and Theoklis E. Zaoutis
Just this week, researchers reported that the incidence of MRSA infections among children admitted to pediatric hospitals in the United States more than tripled between 2002 and 2007. Researchers at the Children’s Hospital of Philadelphia and the University of Pennsylvania found cases of MRSA jumped from 6.7 per 1,000 admissions in 2002 to 21.1 cases per 1,000 admissions in 2007, according to a study released online Monday in the journal Clinical Infectious Diseases.

Featured in Toronto Star
"Pigs, viruses and politics" May 2, 2009
Are Swine Workers in the United States at Increased Risk of Infection with Zoonotic Influenza Virus?
Kendall P. Myers, Christopher W. Olsen, Sharon F. Setterquist, Ana W. Capuano, Kelley J. Donham, Eileen L. Thacker, James A. Merchant, and Gregory C. Gray
Another study, this one published in the U.S. journal Clinical Infectious Diseases in 2006, found that workers in meat-processing plants have a greater likelihood of being infected by some version of the H1N1 flu virus than the general population (the odds of pig farmers getting the disease are significantly greater again).

Featured in Philadelphia Inquirer
"A shot in the arm for vaccines" April 19, 2009
Vaccines: Pneumococcal Vaccination of Elderly Adults: New Paradigms for Protection
Lisa A. Jackson and Edward N. Janoff
Every year, an estimated 915,000 people 65 and older get pneumonia, and 40 percent of them end up in hospitals, according to a 2004 paper in the journal Clinical Infectious Diseases. Pneumonia often kills older people, said Richard Stefanacci, a geriatrician at the University of the Sciences in Philadelphia.

15 February 2007

Volume 44, Number 4
Clinical Infectious Diseases 2007;44:483–492
1058-4838/2007/4404-0002$15.00
DOI: 10.1086/511041
MAJOR ARTICLE

A Prospective Investigation of Outcomes after Hospital Discharge for Endemic, Community‐Acquired Methicillin‐Resistant and ‐Susceptible Staphylococcus aureus Skin Infection

Loren G. Miller,1,3,4

Clifford Quan,2

Anthony Shay,1,3,4

Katayoun Mostafaie,2,4

Kiran Bharadwa,6

Nelly Tan,4,5

Kelli Matayoshi,1,3

Jason Cronin,1,3,4

Jennifer Tan,1,3

Grace Tagudar,1,3 and

Arnold S. Bayer1,3,4

Divisions of 1Infectious Diseases and 2General Internal Medicine and 3Los Angeles Biomedical Research Institute, Harbor–University of California–Los Angeles Medical Center, Torrance, 4David Geffen School of Medicine at the University of California, Los Angeles, and 5University of California, Riverside, California; and 6School of Medicine and Biomedical Sciences, State University of New York, Buffalo

Background.Although community‐acquired methicillin‐resistant Staphylococcus aureus (CA‐MRSA) infection has become increasingly common, prospective data on outcomes of patients with skin infection remain poorly defined.

Methods.We prospectively observed a cohort of 201 patients discharged after hospitalization for CA‐MRSA infection or community‐acquired methicillin‐susceptible S. aureus (CA‐MSSA) infection. Patients were interviewed 30 and 120 days after they received a diagnosis. Our primary outcome was clinical response, defined as no relapse, new S. aureus infection, or need for antibiotics at day 30.

Results.Among 117 patients with skin infection, the nonresponse rate at day 30 was similar among patients with CA‐MRSA infection and those with CA‐MSSA infection (23 [33%] of 70 vs. 13 [28%] of 47 patients; ). Lack of incision and drainage was associated with nonresponse at day 30 ( ), but other clinical factors, including receipt of antibiotics inactive against the infecting strain, were not. Patients with CA‐MSSA infection were more likely to be rehospitalized ( ) and to believe subjectively that they had not been cured ( ) at day 30. At day 30, there was a trend for close contacts of CA‐MRSA–infected patients to develop a similar infection (13% vs. 4%; odds ratio, 3.3; 95% confidence interval, 0.7–15.8; ).

Conclusion.Although it is believed patients with CA‐MRSA skin infection may have more serious outcomes than those with CA‐MSSA skin infection, we found similar outcomes in these 2 groups after hospital discharge. Clinical nonresponse at day 30 was associated with a lack of receipt of incision and drainage. Our data also suggest that close contacts of persons with CA‐MRSA skin infection may have a higher likelihood of acquiring an infection.

Received 4 August 2006; accepted 7 November 2006; electronically published 12 January 2007.

Reprints or correspondence: Dr. Loren G. Miller, Div. of Infectious Diseases, Harbor‐UCLA Medical Center, 1000 W. Carson St., Box 466, Torrance, CA 90509 ().

Cited by

GEORGE Y. LIU. (2009) Molecular Pathogenesis of Staphylococcus aureus Infection. Pediatric Research 65:Supplement, 71R-77R
Online publication date: 1-Jun-2009.
CrossRef
Steven Y. C. Tong, Emma J. Bishop, Rachael A. Lilliebridge, Allen C. Cheng, Zornitsa Spasova‐Penkova, Deborah C. Holt, Philip M. Giffard, Malcolm I. McDonald, Bart J. Currie, and Craig S. Boutlis. (2009) Community‐Associated Strains of Methicillin‐Resistant Staphylococcus aureus and Methicillin‐Susceptible S. aureus in Indigenous Northern Australia: Epidemiology and Outcomes. The Journal of Infectious Diseases 199:10, 1461-1470
Online publication date: 15-May-2009.
M. Li, B. A. Diep, A. E. Villaruz, K. R. Braughton, X. Jiang, F. R. DeLeo, H. F. Chambers, Y. Lu, M. Otto. (2009) From the Cover: Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proceedings of the National Academy of Sciences 106:14, 5883-5888
Online publication date: 7-May-2009.
CrossRef
Mukesh Patel. (2009) Community-Associated Meticillin-Resistant Staphylococcus aureus Infections. Drugs 69:6, 693-716
Online publication date: 1-Feb-2009.
CrossRef
Pramodini Kale-Pradhan, Leonard B Johnson. (2009) Treatment and recurrence management of staphylococcal infections: community-acquired MRSA. Expert Review of Anti-infective Therapy 6:6, 909-915
Online publication date: 1-Jan-2009.
CrossRef
Sheldon L. Kaplan. (2008) COMMENTARY: PREVENTION OF RECURRENT STAPHYLOCOCCAL INFECTIONS. The Pediatric Infectious Disease Journal 27:10, 935-937
Online publication date: 1-Nov-2008.
CrossRef
Lena M. Napolitano. (2008) Early Appropriate Parenteral Antimicrobial Treatment of Complicated Skin and Soft Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus. Surgical Infections 9:s1, s17-s27
Online publication date: 1-Nov-2008.
CrossRef
Lisa L Maragakis, Eli N Perencevich, Sara E Cosgrove. (2008) Clinical and economic burden of antimicrobial resistance. Expert Review of Anti-infective Therapy 6:5, 751-763
Online publication date: 1-Nov-2008.
CrossRef
I. Niniou, S. Vourli, E. Lebessi, M. Foustoukou, A. Vatopoulos, D. G. Pasparakis, D. A. Kafetzis, M. N. Tsolia. (2008) Clinical and molecular epidemiology of community-acquired, methicillin-resistant Staphylococcus aureus infections in children in central Greece. European Journal of Clinical Microbiology & Infectious Diseases 27:9, 831-837
Online publication date: 1-Oct-2008.
CrossRef
Edina Avdic, Sara E Cosgrove. (2008) Management and control strategies for community-associated methicillin-resistant Staphylococcus aureus. Expert Opinion on Pharmacotherapy 9:9, 1463-1479
Online publication date: 1-Jul-2008.
CrossRef
Rachel J. Gordon and Franklin D. Lowy. (2008) Pathogenesis of Methicillin‐Resistant Staphylococcus aureus Infection. Clinical Infectious Diseases 46:s5, S350-S359
Online publication date: 1-Jun-2008.
Martin E. Stryjewski and Henry F. Chambers. (2008) Skin and Soft‐Tissue Infections Caused by Community‐Acquired Methicillin‐Resistant Staphylococcus aureus. Clinical Infectious Diseases 46:s5, S368-S377
Online publication date: 1-Jun-2008.
Y. Carmeli. (2008) Strategies for managing today’s infections. Clinical Microbiology and Infection 14:s3, 22-31
Online publication date: 1-May-2008.
CrossRef
Loren G. Miller and Binh An Diep. (2008) Clinical Practice: Colonization, Fomites, and Virulence: Rethinking the Pathogenesis of Community‐Associated Methicillin‐Resistant Staphylococcus aureus Infection. Clinical Infectious Diseases 46:5, 752-760
Online publication date: 1-Mar-2008.
Richard A. Proctor. (2008) Clinical Practice: Role of Folate Antagonists in the Treatment of Methicillin‐Resistant Staphylococcus aureus Infection. Clinical Infectious Diseases 46:4, 584-593
Online publication date: 15-Feb-2008.
Rachel J. Gorwitz. (2008) A Review of Community-Associated Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections. The Pediatric Infectious Disease Journal 27:1, 1-7
Online publication date: 1-Feb-2008.
CrossRef
Fredrick M. Abrahamian, Eric W. Snyder. (2007) Community-associated methicillin-resistant Staphylococcus aureus: Incidence, clinical presentation, and treatment decisions. Current Infectious Disease Reports 9:5, 391-397
Online publication date: 1-Oct-2007.
CrossRef
  • Presented in part: 43rd Annual Meeting of the Infectious Diseases Society of America, San Francisco, California, October 2005 (abstract 1059).

Close Popup